Spyglass Pharma, Inc. · NASDAQ:SGP
Spyglass Pharma, Inc. shareholders
As of Jun 30, 2026, 49 institutions reported holding Spyglass Pharma, Inc., 78.1% of its shares. Largest: Ra Capital Management, L.P., NEA Management Company, LLC and Sands Capital Alternatives, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Spyglass Pharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 8.02M | 24.0% | no change | Aug 14, 2026 |
| NEA Management Company, LLC | 7.39M | 22.1% | no change | Aug 14, 2026 |
| Sands Capital Alternatives, LLC | 2.5M | 7.5% | no change | Aug 13, 2026 |
| Samsara Biocapital, LLC | 2.11M | 6.3% | no change | Aug 14, 2026 |
| BlackRock | 712K | 2.1% | +567K | Aug 7, 2026 |
| T. Rowe Price | 674K | 2.0% | −30,297 | Aug 14, 2026 |
| Vestal Point Capital, LP | 670K | 2.0% | +3,240 | Aug 14, 2026 |
| JPMorgan | 630K | 1.9% | +52,630 | Aug 12, 2026 |
| Vanguard | 583K | 1.7% | +80,158 | Aug 13, 2026 |
| Deerfield Management Company, L.P. | 550K | 1.6% | no change | Aug 14, 2026 |